1-15 of 15
Xuejun Zhang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

JAK/Rock Inhibitor Rovadicitinib for Glucocorticoid-Refractory or -Dependent Chronic Graft-Versus-Host Disease：Updated Results of Multicenter, Phase 1b/2a Trial

Yanmin Zhao, Yi Luo, Jimin Shi, Shunqing Wang, Caixia Wang, Erlie Jiang, Chen Liang, Xiaoyu Zhu, Xuejun Zhang, Fankai Meng, Hua Jin, Yeqian Zhao, Jian Yu, Xiaoyu Lai, Lizhen Liu, Huarui Fu, Yishan Ye, Congxiao Zhang, Tao Wang, Lifan Tu, Xunqiang Wang, He Huang
Journal: Blood
Blood (2024) 144 (Supplement 1): 97.
https://doi.org/10.1182/blood-2024-204703
Published: 2024
Journal Articles

A Phase I/II Trial of the FLT3 Kinase Inhibitor XY0206 in Patients with Relapsed/Refractory Acute Myeloid Leukemia

Junyuan Qi, Lin Song, Xudong Wei, Zhimin Zhai, Anyou Wang, Daozi Jiang, Yang Liang, Fei Li, Zhongxing Jiang, Xuejun Zhang, Qunyi Guo, Hongmei Jing, Yajing Xu, Xiangmin Tong, Jianxiang Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 2908.
https://doi.org/10.1182/blood-2023-183088
Published: 2023
Journal Articles

Phase I Study of TQB3455, a Selective Inhibitor of IDH2 with Favorable Safety and More Potent Efficacy to IDH2-R172K Mutation, for Acute Myeloid Leukemia and Myelodysplastic Syndrome

Hao Jiang, Xudong Wei, Chunkang Chang, Hongbing Ma, Xuejun Zhang, Xiao-Jun Huang
Journal: Blood
Blood (2022) 140 (Supplement 1): 9082–9083.
https://doi.org/10.1182/blood-2022-164984
Published: 2022
Journal Articles

Allogeneic CAR-T Cell Therapy for Treatment of Relapse after Allo-HSCT in Patients with Refractory CML Lymphoid Blast Crisis: Significance of HLA Matched Donor/Patient Pair in the Safety/Efficacy of CAR-T Cell Therapy

Kai Sun, MD, Xuejun Zhang, MD, Zhen Wang, MD, Yuqing Chen, MD, Lei Zhang, MD, Wei Cheng, MD, Mingyue Shi, MD, Lei Huo, MD, Yanliang Bai, MD, Xiaona Niu, MD, Honggang Guo, MD, Jing Yang, MD, Chunrong Tong, MD, AlexH Chang, MD, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4275.
https://doi.org/10.1182/blood-2018-99-115768
Published: 2018
Journal Articles

Transiently Elevated AST/LDH Are Associated with Clinical Response to Recombinant Circularly Permuted TRAIL (CPT) Plus Thalidomide in Patients with Relapsed and/or Refractory Multiple Myeloma

Wenming Chen, MD, Peng Wei, PhD, Shifang Yang, PhD, Xiangjun Zheng, Lugui Qiu, MD, Jian Hou, MD PhD, Xuejun Zhang, MD, Zhao Wang, Xiaoyan Ke, MD PhD, Ling Pan, MDPhD, Hongyan Pang, PhD
Journal: Blood
Blood (2014) 124 (21): 3478.
https://doi.org/10.1182/blood.V124.21.3478.3478
Published: 2014
Journal Articles

Phase Ib Study of Recombinant Circularly Permuted TRAIL (CPT) in Relapsed or Refractory multiple Myeloma Patients

Wenming Chen, MD, Lugui Qiu, MD, Jian Hou, MD, PhD, Xuejun Zhang, Xiaoyan Ke, MD, PhD, Zhao Wang, MD, PhD, Fang Zhou, Shifang Yang, PhD, Yaozhong Zhao, Yun Leng, Hao Xi, Fuxu Wang, Bing Zhu
Journal: Blood
Blood (2012) 120 (21): 1857.
https://doi.org/10.1182/blood.V120.21.1857.1857
Published: 2012
Journal Articles

Recombinant Circularly Permuted TRAIL (CPT) for the Treatment of Relapsed or Refractory Multiple Myeloma: An Open-Label, Multicenter Phase II Clinical Trial

Wenming Chen, MD, Lugui Qiu, MD, Jian Hou, MD, PhD, Yaozhong Zhao, Ling Pan, Shifang Yang, PhD, Yun Leng, Hao Xi, Xuejun Zhang, Junsheng Cui, Na Wei
Journal: Blood
Blood (2012) 120 (21): 78.
https://doi.org/10.1182/blood.V120.21.78.78
Published: 2012
Journal Articles

Deficiency of SATB1 expression in Sézary cells causes apoptosis resistance by regulating FasL/CD95L transcription

Yang Wang, Mingwan Su, Liang L. Zhou, Ping Tu, Xuejun Zhang, Xiaoyan Jiang, Youwen Zhou
Journal: Blood
Blood (2011) 117 (14): 3826–3835.
https://doi.org/10.1182/blood-2010-07-294819
Published: 2011
Includes: Supplemental data
Journal Articles

PTEN Regulates VEGF, VEGFR1 Expression and Its Clinical Significance in Myeloid Leukemia.

Zhiyong Cheng, Lin Pan, MD, Xiaoling Guo, Xuejun Zhang, Fuxu Wang
Journal: Blood
Blood (2009) 114 (22): 1001.
https://doi.org/10.1182/blood.V114.22.1001.1001
Published: 2009
Journal Articles

In Vivo Phycocyanin Treatment of S180 Bearing-Mice: Increase in Immunic Function and Inhibition of Tumor Growth.

Ling Pan, Wei Hao, Xuejun Zhang, Zhiyun Niu, Fuxu Wang, Zuoren Dong
Journal: Blood
Blood (2006) 108 (11): 5191.
https://doi.org/10.1182/blood.V108.11.5191.5191
Published: 2006
Journal Articles

Effects of rmhTRAIL Combined with Daunorubicin in Inducing Apoptosis of Leukemia Cell Lines and Its Mechanism.

Xuejun Zhang, Li Wen, Fuxu Wang, Ling Pan, Jianmin Luo, Zuoren Dong
Journal: Blood
Blood (2006) 108 (11): 1986.
https://doi.org/10.1182/blood.V108.11.1986.1986
Published: 2006
Journal Articles

Expression and Mutation Analysis of the Myc Antagonist Gene Mad1 in Acute Leukemia.

Ling Pan, Xuejun Zhang, Xiaohui Suo, Fuxu Wang, Zhiyun Niu, Zuoren Dong
Journal: Blood
Blood (2006) 108 (11): 4331.
https://doi.org/10.1182/blood.V108.11.4331.4331
Published: 2006
Journal Articles

Preclinical Research on Idiotype Vaccine Against B Cell Lymphoma.

Fuxu Wang, Bing Zhao, Ling Pan, Xuejun Zhang, Jianmin Luo, Zuoren Dong
Journal: Blood
Blood (2006) 108 (11): 4744.
https://doi.org/10.1182/blood.V108.11.4744.4744
Published: 2006
Journal Articles

Effects of Integrin α 5 β 1 -Mediated Signal TransductionPathways on the Proliferation and Apoptosis of K562 and CML Cells.

Ling Pan, Zhiyun Niu, Xuejun Zhang, Fuxu Wang, Xiaohui Suo, Zuoren Dong
Journal: Blood
Blood (2006) 108 (11): 4797.
https://doi.org/10.1182/blood.V108.11.4797.4797
Published: 2006
Journal Articles

FTY720 suppresses humoral immunity by inhibiting germinal center reaction

Shuhua Han, Xuejun Zhang, Gangdou Wang, Hui Guan, Gabriela Garcia, Ping Li, Lili Feng, Biao Zheng
Journal: Blood
Blood (2004) 104 (13): 4129–4133.
https://doi.org/10.1182/blood-2004-06-2075
Published: 2004